Assuring integrity in Obstetrics and Gynecology research
- PMID: 35686650
- DOI: 10.1002/ijgo.14292
Assuring integrity in Obstetrics and Gynecology research
Comment in
-
Letter to the Editor: Research and consensus is required concerning integrity of randomized clinical trials.Int J Gynaecol Obstet. 2022 Nov;159(2):613. doi: 10.1002/ijgo.14394. Epub 2022 Aug 28. Int J Gynaecol Obstet. 2022. PMID: 36030408 No abstract available.
References
REFERENCES
-
- Alfirevic Z. Retracted papers are only the tip of the iceberg of untrustworthy evidence. Am J Obstet Gynecol MFM. 2020;2:100223. doi:10.1016/j.ajogmf.2020.100223
-
- Mehra MR, Ruschitzka F, Patel AN. Retraction-hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;395:P1820.
-
- Anderson K, Romero R, Odibo AO, et al. Quality criteria for randomized controlled studies: obstetrical journal guidelines. Am J Obstet Gynecol MFM. 2021;3:100334. doi:10.1016/j.ajogmf.2021.100334
-
- COPE Council. COPE Flowcharts and Infographics - General Approach to Publication Ethics for the Editorial Office 10.24318/cope.2019.2.24. Accessed May 26, 2022.
-
- IJGO. Retraction: Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome. Int J Gynecol Obstet. 2022;158. doi:10.1002/ijgo.14281.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources